Ensol Bioscience Inc. has been building ETONS(Ensol Trans-Omics Network System), a prediction system for toxic side effects by verifying the more efficient new drug candidate materials based on its core technology, KISDD(Knowledge-based In Silico Drug Discovery). KISDD is a "bio big data based'' search platform that scans for any new drug candidates for the cure of incurable diseases.
Ensol’s main focused diseases are Degenerative Disc Disease (DDD), Osteoarthritis (OA) Disease, TripleNegative Breast Cancer (TNBC), Alzheimer’s Disease (AD), and Type 1 Diabetes (T1D).
Ensol is now enlisted on KONEX and plans to move to KOSDAQ, a larger public stock exchange bourse in South Korea, for stockholder’s conveniences and company valuation increase.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 51, Techno 10-Ro, Yuseong-Gu,daejeon 34036,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ensolbio.co.kr
- Keywords
- BioTNS.
- HQ
- Yuseong-gu, Daejeon
Ensol Biosciences Inc. Questions
Ensol Biosciences Inc.'s website is http://www.ensolbio.co.kr
Ensol Biosciences Inc.'s LinkedIn profile is https://kr.linkedin.com/company/ensol-biosciences-inc
Ensol Biosciences Inc. has
8 employees.
View email and phone details for 8
employees at Ensol Biosciences Inc..
Ensol Biosciences Inc.'s industry is
Biotechnology Research
Ensol Biosciences Inc.'s top competitors are
Plasmaimpact,
Nettargets, (주)넷타겟,
Biotns,
Naieel Technology,
Biopro Scientific,
Kaist Graduate School Of Bio Innovation Management,
Biorevert Inc.,
Global Shapers Community - Daejeon Hub,
Cripco,
Spine Biopharma.
Ensol Biosciences Inc.'s categories are Biotechnology Research
Ensol Biosciences Inc.'s founding year is 2001
